News on research and diagnostics in autoimmune disorders including rheumatoid arthritis, lupus, multiple sclerosis, and more.
The company's revenue growth was driven in part by a US copromotion alliance for Janssen Biotech's rheumatoid arthritis drug Simponi.
The four kits are compatible with the i-Track automated analyzer for biotherapy monitoring, which received CE marking in late 2019.
The immune sequencing firm has engaged the FDA in discussions over how to get regulatory approval for one test for several seemingly different diseases.
The company plans to use the funds to fuel its diagnostic development work, focused on predicting drug response in various autoimmune diseases.
The test is designed to analyze the expression of 17 genes in order to differentiate mild and aggressive forms of Crohn's disease and ulcerative colitis.
